Urine 1,6-hexamethylene diamine (HDA) levels among workers exposed to 1,6-hexamethylene diisocyanate (HDI)

Annals of Occupational Hygiene

Volumn 54, Issue 6, 2010, Pages 678-691

  Gaines, Linda G T ^a   Fent, Kenneth W ^a   Flack, Sheila L ^a   Thomasen, Jennifer M ^a   Ball, Louise M ^a   Richardson, David B ^a   Ding, Kai ^a   Whittaker, Stephen G ^b   Nylander French, Leena A ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

Author keywords

1,6 hexamethylene diamine; 1,6 hexamethylene diisocyanate; biomarkers; creatinine; dermal exposure; inhalation exposure; urine analysis

Indexed keywords

1,6-HEXAMETHYLENE DIAMINE; CREATININE; DERMAL EXPOSURE; HEXAMETHYLENE DIISOCYANATE; INHALATION EXPOSURE; URINE ANALYSIS;

BIOMARKERS; CYCLOHEXANE; DIRECTIVE ANTENNAS; RESPIRATORS; WATER CONTENT;

BODY FLUIDS;

1,6 HEXANEDIAMINE; 1,6-DIAMINOHEXANE; 1,6-HEXAMETHYLENE DIISOCYANATE; BIOLOGICAL MARKER; CREATININE; CYANIC ACID DERIVATIVE; DIAMINE; HEXAMETHYLENE DIISOCYANATE; PAINT;

ADULT; AIR POLLUTANT; ARTICLE; BLOOD; CAR; DOSE RESPONSE; ENVIRONMENTAL MONITORING; EXPOSURE; GAS MASK; HALF LIFE TIME; HUMAN; HYDROLYSIS; INDOOR AIR POLLUTION; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PROTECTIVE CLOTHING; SKIN ABSORPTION; STATISTICAL MODEL; STATISTICS; URINE; UTILIZATION REVIEW; WORKPLACE;

ADULT; AIR POLLUTANTS, OCCUPATIONAL; AIR POLLUTION, INDOOR; AUTOMOBILES; BIOLOGICAL MARKERS; CREATININE; CYANATES; DIAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL MONITORING; HALF-LIFE; HUMANS; HYDROLYSIS; INHALATION EXPOSURE; LINEAR MODELS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PAINT; PROTECTIVE CLOTHING; RESPIRATORY PROTECTIVE DEVICES; SKIN ABSORPTION; WORKPLACE; YOUNG ADULT;

EID: 77955873083     PISSN: 00034878     EISSN: 14753162     Source Type: Journal    
DOI: 10.1093/annhyg/meq041     Document Type: Article

References (39)

1. Almeida AM, Castel-Branco MM, Falcao AC. (2002) Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods. J Chromatogr B Analyt Technol Biomed Life Sci; 774: 215-222
2. Austin S. (2007) Biological monitoring of TDI-derived amines in polyurethane foam production. Occup Med (Lond); 57: 444-448
3. Barr DB, Wilder LC, Caudill SP et al. (2005) Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect; 113: 192-200.
4. Bello D, Herrick CA, Smith TJ et al. (2007) Skin exposure to isocyanates: reasons for concern. Environ Health Perspect; 115: 328-335
5. Berode M, Testa B, Savolainen H. (1991) Bicarbonatecatalyzed hydrolysis of hexamethylene diisocyanate to 1,6-diaminohexane. Toxicol Lett; 56: 173-178
6. Brorson T, Skarping G, Nielsen J. (1990) Biological monitoring of isocyanates and related amines. II. Test chamber exposure of humans to 1,6-hexamethylene diisocyanate (HDI). Int Arch Occup Environ Health; 62: 385-389
7. Brorson T, Skarping G, Sango C. (1991) Biological monitoring of isocyanates and related amines. IV. 2,4-and 2,6-toluenediamine in hydrolysed plasma and urine after test-chamber exposure of humans to 2, 4-and 2,6-toluene diisocyanate. Int Arch Occup Environ Health; 63: 253-259
8. Cocker J. (2007) Biological monitoring for isocyanates. Occup Med (Lond); 57: 391-393
9. Dalene M, Skarping G, Lind P. (1997) Workers exposed to thermal degradation products of TDI-and MDI-based polyurethane: biomonitoring of 2,4-TDA, 2,6-TDA, and 4,4'-MDA in hydrolyzed urine and plasma. Am Ind Hyg Assoc J; 58: 587-591
10. EPA. (2004) Statistical protocol for the determination of the single-laboratory lowest concentration minimum reporting level (LCMRL) and validation of laboratory performance at or below the minimum reporting level (MRL). US EPAOffice of Ground Water and Drinking Water Standards and Risk Management Division EPA, Cincinnati, OH. Document # 815-R-05-006.
11. Exocell. (2004) The creatinine companion. Philadelphia, PA: Exocell.
12. Fent KW, Gaines LG, Thomasen JM et al. (2009a) Quantification and statistical modeling-part I: breathing-zone concentrations of monomeric and polymeric 1,6-hexamethylene diisocyanate. Ann Occup Hyg; 53: 677-689
13. Fent KW, Gaines LG, Thomasen JM et al. (2009b) Quantification and statistical modeling-part II: dermal concentrations of monomeric and polymeric 1,6-hexamethylene diisocyanate. Ann Occup Hyg; 53: 691-702.
14. Fent KW, Jayaraj K, Ball LM et al. (2008) Quantitative monitoring of dermal and inhalation exposure to 1,6-hexamethylene diisocyanate monomer and oligomers. J Environ Monit; 10: 500-507
15. Flack S, Ball LM, Nylander-French LA. (2010) Occupational exposure to HDI: progress and challenges in biomarker analysis. J Chromatogr B Analyt Technol Biomed Life Sci; doi:10.1016/j.jchromb.2010.01.012.
16. HSE. (2006) Urine sampling for isocyanate exposure measurement. Health and Safety Executive. http://www.hse.gov.uk/ pubns/guidance/g408.pdf. Accessed 20 September 2009.
17. Kaaria K, Hirvonen A, Norppa H et al. (2001a) Exposure to 2,4-and 2,6-toluene diisocyanate (TDI) during production of flexible foam: determination of airborne TDI and urinary 2,4-and 2,6-toluenediamine (TDA). Analyst; 126: 1025-1031
18. Kaaria K, Hirvonen A, Norppa H et al. (2001b) Exposure to 4,4'-methylenediphenyl diisocyanate (MDI) during moulding of rigid polyurethane foam: determination of airborne MDI and urinary 4,4'-methylenedianiline (MDA). Analyst; 126: 476-479
19. Lind P, Dalene M, Skarping G et al. (1996) Toxicokinetics of 2,4-and 2,6-toluenediamine in hydrolysed urine and plasma after occupational exposure to 2,4-and 2,6-toluene diisocyanate. Occup Environ Med; 53: 94-99
20. Lind P, Dalene M, Tinnerberg H et al. (1997) Biomarkers in hydrolysed urine, plasma and erythrocytes among workers exposed to thermal degradation products from toluene diisocyanate foam. Analyst; 122: 51-56
21. Liu Y, Berode M, Stowe MH et al. (2004) Urinary hexane diamine to assess respiratory exposure to hexamethylene diisocyanate aerosol: a human inhalation study. Int J Occup Environ Health; 10: 262-271
22. Lubin JH, Colt JS, Camann D et al. (2004) Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect; 112: 1691-1696
23. Maitre A, Berode M, Perdrix A et al. (1996) Urinary hexane diamine as an indicator of occupational exposure to hexamethylene diisocyanate. Int Arch Occup Environ Health; 69: 65-68
24. Murray R. (1987) Creatinine. In: Pesce A, Kaplan L, editors. Methods in clinical chemistry. St Louis, MO: CV Mosby Co; pp. 10-17
25. Orelien JG, Edwards LJ. (2008) Fixed-effect variable selection in linear mixed models using R2 statistics. Comput Stat Data Anal; 52: 1896-1907
26. OSHA. (2006) Respiratory protection-1910.134, Regulation (Standards-29 CFR). U.S. Department of Labor. http:// www.osha.gov/. Accessed 15 September 2008.
27. Pauluhn J, Lewalter J. (2002) Analysis of markers of exposure to polymeric methylene-diphenyl diisocyanate (pMDI) in rats: a comparison of dermal and inhalation routes of exposure. Exp Toxicol Pathol; 54: 135-146
28. Pronk A, Yu F, Vlaanderen J et al. (2006) Dermal, inhalation and internal exposure to 1,6-HDI and its oligomers in car body repair shop workers and industrial spray painters. Occup Environ Med; 63: 624-631
29. Rosenberg C, Nikkila K, Henriks-Eckerman ML et al. (2002) Biological monitoring of aromatic diisocyanates in workers exposed to thermal degradation products of polyurethanes. J Environ Monit; 4: 711-716
30. Sabbioni G,Wesp H, Lewalter J et al. (2007) Determination of isocyanate biomarkers in construction site workers. Biomarkers; 12: 468-483
31. Sennbro CJ, Lindh CH, Mattsson C et al. (2006) Biological monitoring of exposure to 1,5-naphthalene diisocyanate and 4,4'-methylenediphenyl diisocyanate. Int Arch Occup Environ Health; 79: 647-653
32. Sennbro CJ, Lindh CH, Tinnerberg H et al. (2003) Development, validation and characterization of an analytical method for the quantification of hydrolysable urinary metabolites and plasma protein adducts of 2,4-and 2,6-toluene diisocyanate, 1,5-naphthalene diisocyanate and 4,4'- methylenediphenyl diisocyanate. Biomarkers; 8: 204-217
33. Sennbro CJ, Lindh CH, Tinnerberg H et al. (2004) Biological monitoring of exposure to toluene diisocyanate. Scand J Work Environ Health; 30: 371-378
34. Sepai O, Henschler D, Sabbioni G. (1995) Albumin adducts, hemoglobin adducts and urinary metabolites in workers exposed to 4,4'-methylenediphenyl diisocyanate. Carcinogenesis; 16: 2583-2587
35. Skarping G, Brorson T, Sango C. (1991) Biological monitoring of isocyanates and related amines. III. Test chamber exposure of humans to toluene diisocyanate. Int Arch Occup Environ Health; 63: 83-88
36. Tinnerberg H, Skarping G, Dalene M et al. (1995) Test chamber exposure of humans to 1,6-hexamethylene diisocyanate and isophorone diisocyanate. Int Arch Occup Environ Health; 67: 367-374
37. Vonesh E, Chinchilli V. (1997) Linear and nonlinear models for the analysis of repeated measurements. New York, NY: Marcel Dekker.
38. Xu R. (2003) Measuring explained variation in linear mixed effects models. Stat Med; 22: 3527-3541
39. Yeh HJ, Lin WC, Shih TS et al. (2008) Urinary excretion of toluene diisocyanates in rats following dermal exposure. J Appl Toxicol; 28: 189-195